R G Boyle
Independent Representative of the Investment Advisory Panel at O2h Ventures
About
Founder and CEO of Sentinel Oncology, a medicinal chemist with 25+ years of industry experience at Pfizer, Millennium, and Astex. He is a named inventor on 50+ patents and publications on small-molecule therapeutics.
Colleagues at O2h Ventures
Ajit Singh Guller
Marketing Manager at O2h Ventures
Andy Morley
Principal at O2h Ventures
Catherine Beech
Independent Representative to the Investment Advisory Panel at O2h Ventures
Catherine Stace
VP - Strategic Relationships at O2h Ventures
Cengiz Tarhan
Independent Representative of the Investment Advisory Panel at O2h Ventures
Chris Reid
Venture Partner at O2h Ventures
Chris White
Vice President, Business Development at O2h Ventures
Dr Chris Torrance
Independent Representative of the Investment Advisory Panel at O2h Ventures